GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai Haohai Biological Technology Co Ltd (SHSE:688366) » Definitions » ROE %

Shanghai Haohai Biological Technology Co (SHSE:688366) ROE % : 9.63% (As of Jun. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Shanghai Haohai Biological Technology Co ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Shanghai Haohai Biological Technology Co's annualized net income for the quarter that ended in Jun. 2024 was ¥551 Mil. Shanghai Haohai Biological Technology Co's average Total Stockholders Equity over the quarter that ended in Jun. 2024 was ¥5,722 Mil. Therefore, Shanghai Haohai Biological Technology Co's annualized ROE % for the quarter that ended in Jun. 2024 was 9.63%.

The historical rank and industry rank for Shanghai Haohai Biological Technology Co's ROE % or its related term are showing as below:

SHSE:688366' s ROE % Range Over the Past 10 Years
Min: 3.06   Med: 9.36   Max: 30.9
Current: 7.57

During the past 10 years, Shanghai Haohai Biological Technology Co's highest ROE % was 30.90%. The lowest was 3.06%. And the median was 9.36%.

SHSE:688366's ROE % is ranked better than
88.05% of 1305 companies
in the Biotechnology industry
Industry Median: -43.68 vs SHSE:688366: 7.57

Shanghai Haohai Biological Technology Co ROE % Historical Data

The historical data trend for Shanghai Haohai Biological Technology Co's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Haohai Biological Technology Co ROE % Chart

Shanghai Haohai Biological Technology Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.18 4.20 6.29 3.21 7.45

Shanghai Haohai Biological Technology Co Quarterly Data
Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.52 6.29 6.84 9.63 7.43

Competitive Comparison of Shanghai Haohai Biological Technology Co's ROE %

For the Biotechnology subindustry, Shanghai Haohai Biological Technology Co's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Haohai Biological Technology Co's ROE % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shanghai Haohai Biological Technology Co's ROE % distribution charts can be found below:

* The bar in red indicates where Shanghai Haohai Biological Technology Co's ROE % falls into.



Shanghai Haohai Biological Technology Co ROE % Calculation

Shanghai Haohai Biological Technology Co's annualized ROE % for the fiscal year that ended in Dec. 2023 is calculated as

ROE %=Net Income (A: Dec. 2023 )/( (Total Stockholders Equity (A: Dec. 2022 )+Total Stockholders Equity (A: Dec. 2023 ))/ count )
=416.121/( (5514.609+5650.064)/ 2 )
=416.121/5582.3365
=7.45 %

Shanghai Haohai Biological Technology Co's annualized ROE % for the quarter that ended in Jun. 2024 is calculated as

ROE %=Net Income (Q: Jun. 2024 )/( (Total Stockholders Equity (Q: Mar. 2024 )+Total Stockholders Equity (Q: Jun. 2024 ))/ count )
=550.968/( (5755.069+5688.17)/ 2 )
=550.968/5721.6195
=9.63 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Jun. 2024) net income data. ROE % is displayed in the 30-year financial page.


Shanghai Haohai Biological Technology Co  (SHSE:688366) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Jun. 2024 )
=Net Income/Total Stockholders Equity
=550.968/5721.6195
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(550.968 / 3033.792)*(3033.792 / 7217.57)*(7217.57 / 5721.6195)
=Net Margin %*Asset Turnover*Equity Multiplier
=18.16 %*0.4203*1.2615
=ROA %*Equity Multiplier
=7.63 %*1.2615
=9.63 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Jun. 2024 )
=Net Income/Total Stockholders Equity
=550.968/5721.6195
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (550.968 / 593.308) * (593.308 / 597.92) * (597.92 / 3033.792) * (3033.792 / 7217.57) * (7217.57 / 5721.6195)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.9286 * 0.9923 * 19.71 % * 0.4203 * 1.2615
=9.63 %

Note: The net income data used here is four times the quarterly (Jun. 2024) net income data. The Revenue data used here is four times the quarterly (Jun. 2024) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Shanghai Haohai Biological Technology Co ROE % Related Terms

Thank you for viewing the detailed overview of Shanghai Haohai Biological Technology Co's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Haohai Biological Technology Co Business Description

Traded in Other Exchanges
Address
No. 1386 Hongqiao Road, 23rd Floor, WenGuang Plaza, Changning District, Shanghai, CHN
Shanghai Haohai Biological Technology Co Ltd is engaged in the manufacturing and sale of biologicals, medical hyaluronate, and ophthalmology products. The Company's operating activities are related to single operating segment which is the manufacture and sale of biologicals, medical hyaluronate and intraocular lens, research and development of biological engineering and pharmaceutical products and the provision of related services. Its products are categorized into four types comprising ophthalmology, medical aesthetics, orthopedics, and anti-adhesion. Geographically, it has operations in Mainland China which is the key revenue driver, the United States, the United Kingdom, and other countries.
Executives
Du Peng Core technical personnel
Hou Yong Tai Director, core technical staff
Jiang Li Xia Core technical personnel
Core technical personnel
Liu Lu Core technical personnel
Ren Cai Xia senior management
Wang Wen Bin Senior management, core technical personnel
Tang Min Jie Directors, senior managers
Wu Jian Ying Directors, senior managers
Liu Yuan Zhong Supervisors
Huang Ming Director
Zhang Jun Dong Senior management, core technical personnel
You Jie Director
Tian Min senior management
Chen Yi Yi Director

Shanghai Haohai Biological Technology Co Headlines

No Headlines